BRANFORD, Conn., Nov. 8, 2012 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED) today reported financial results for the three and nine months ended September 30, 2012. Total worldwide sales in the third quarter were $6.1 million. This represents a return to growth with a 6% gain over the prior-year third quarter. The net loss applicable to common stockholders for the third quarter of 2012 was $1.8 million, or ($0.14) per common share, compared with a net loss applicable to common stockholders of $2.1 million, or ($0.16) per common share, for the third quarter of 2011. Highlights of the third quarter include:
